EP 1539741 A1 20050615 - 2-THIO-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS
Title (en)
2-THIO-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS
Title (de)
2-THIO-SUBSTITUIERTE IMIDAZOLDERIVATE UND IHRE VERWENDUNG IN DER PHARMAZIE
Title (fr)
DERIVES D'IMIDAZOL 2-THIO-SUBSTITUES ET LEUR UTILISATION DANS LE DOMAINE PHARMACEUTIQUE
Publication
Application
Priority
- DE 10238045 A 20020820
- EP 0309219 W 20030820
Abstract (en)
[origin: CA2501849A1] The invention relates to 2-thio-substituted imidazole derivatives of formula (I), wherein the radicals R1, R2, R3 and m have the meanings as cited in the description. The inventive compounds comprise an immunomodulatory action and/or an action that inhibits the release of cytokines and are thus suited for treating diseases associated with a disorder of the immune system.</SDOA B>
IPC 1-7
IPC 8 full level
A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/4709 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61P 1/02 (2006.01); A61P 1/04 (2006.01); A61P 1/16 (2006.01); A61P 3/10 (2006.01); A61P 9/00 (2006.01); A61P 9/04 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 17/06 (2006.01); A61P 17/14 (2006.01); A61P 19/02 (2006.01); A61P 19/06 (2006.01); A61P 19/10 (2006.01); A61P 25/00 (2006.01); A61P 25/04 (2006.01); A61P 25/08 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 37/02 (2006.01); A61P 37/06 (2006.01); A61P 37/08 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 453/02 (2006.01); C07D 493/04 (2006.01)
CPC (source: EP KR US)
A61P 1/02 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 17/14 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/06 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/18 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 37/08 (2017.12 - EP); C07D 401/04 (2013.01 - EP KR US); C07D 401/14 (2013.01 - KR)
Citation (search report)
See references of WO 2004018458A1
Citation (examination)
WAGNER, G. K. ET AL.: "Indentification of regioisomers in a series of N-substituted pyridin-4-yl imidazole derivatives by regiospecific synthesis, GC/MS, and 1H NMR.", J. ORG. CHEM., vol. 68, 2003, pages 4527 - 4530, XP002382672, DOI: doi:10.1021/jo026619w
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
DE 10238045 A1 20040304; AU 2003267000 A1 20040311; AU 2003267000 B2 20090528; BR 0313277 A 20050621; CA 2501849 A1 20040304; CN 100396677 C 20080625; CN 1675197 A 20050928; EP 1539741 A1 20050615; HR P20050239 A2 20051031; IS 7740 A 20050314; JP 2005539035 A 20051222; KR 20050058419 A 20050616; MX PA05001985 A 20050527; NO 20051477 L 20050519; PL 375793 A1 20051212; RS 20050131 A 20070604; RU 2005107726 A 20060120; RU 2331638 C2 20080820; UA 80718 C2 20071025; US 2006235054 A1 20061019; US 7582660 B2 20090901; WO 2004018458 A1 20040304; ZA 200501455 B 20061025
DOCDB simple family (application)
DE 10238045 A 20020820; AU 2003267000 A 20030820; BR 0313277 A 20030820; CA 2501849 A 20030820; CN 03819750 A 20030820; EP 0309219 W 20030820; EP 03747916 A 20030820; HR P20050239 A 20050314; IS 7740 A 20050314; JP 2004530221 A 20030820; KR 20057002947 A 20050221; MX PA05001985 A 20030820; NO 20051477 A 20050318; PL 37579303 A 20030820; RU 2005107726 A 20030820; UA 2005002484 A 20030820; US 52448605 A 20051117; YU P20050131 A 20030820; ZA 200501455 A 20050218